Bank Pictet & Cie (Europe)’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,334
Closed -$214K 186
2021
Q4
$214K Buy
2,334
+281
+14% +$33.6K 0.01% 174
2021
Q3
$260K Sell
2,053
-181
-8% -$26.4K 0.01% 151
2021
Q2
$371K Buy
2,234
+325
+17% +$52.7K 0.01% 150
2021
Q1
$347K Buy
+1,909
New +$443K 0.01% 146

Other funds holding TDOC

Bank Pictet & Cie (Europe)'s TDOC Position: Q1 2022 in Review

Bank Pictet & Cie (Europe) sold out of Teladoc Health (TDOC) in Q1 2022, closing a stake of 2,334 shares — an estimated $214K sold.

Bank Pictet & Cie (Europe) first reported a position in TDOC in Q1 2021 and held it in 4 quarters. The position peaked at $371K in Q2 2021. 680 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.

  • Bank Pictet & Cie (Europe) reported no remaining Teladoc Health position as of Q1 2022 after selling out during the quarter.
  • Bank Pictet & Cie (Europe) sold 2,334 Teladoc Health shares in Q1 2022, an estimated $214K.
  • Bank Pictet & Cie (Europe) first reported a position in Teladoc Health in Q1 2021 and held it in 4 quarters.
  • Bank Pictet & Cie (Europe)'s Teladoc Health position peaked at $371K in Q2 2021.
  • 680 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q1 2022, filed 4 May 2022.